Evidence map›Paper›PMID 40917870›Full record

ArticleNeuroimage. Reports2025

ADHD diagnostics and severity assessment using topological manifold learning of resting-state functional magnetic resonance imaging (rs-fMRI).

Yan Xue, Yuxiang Zhou, Xiaoxu Na, Xiawei Ou, Yongming Liu

Abstract read
In one paragraph

Article in Neuroimage. Reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan XueArizona State University, Tempe, AZ, 85287, USA.
Yuxiang ZhouMayo Clinic, Phoenix, AZ, 85054, USA.
Xiaoxu NaUniversity of Arkansas for Medical Sciences, AR, 72205, USA.
Xiawei OuUniversity of Arkansas for Medical Sciences, AR, 72205, USA.
Yongming LiuArizona State University, Tempe, AZ, 85287, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-intrusive neuroimaging technology offers fast and robust diagnostic tools for neuro-disorder disease diagnosis, such as Attention-Deficit/Hyperactivity Disorder (ADHD). Resting-state functional magnetic imaging (rs-fMRI) has been demonstrated to have great potential for such applications due to its unique capability and convenience in providing spatial-temporal brain imaging. One critical challenge of using rs-fMRI data is the high dimensionality for both spatial and temporal domains. Thus, direct use of rs-fMRI data for the diagnosis will usually perform poorly due to the "curse of dimensionality." This paper proposes a novel nonlinear dimension reduction technique for rs-fMRI data for easy downstream analysis, such as diagnostics, regression, and visualization. The proposed method integrates the Curvature Augmented Manifold Embedding and Learning (CAMEL) algorithm with key rs-fMRI features, such as Amplitude of Low-Frequency Fluctuations (ALFF), Regional Homogeneity (ReHo), and Functional Connectivity (FC). The ADHD diagnosis problem is formulated as a classification problem in the reduced latent space and is validated with 551 data points from an open fMRI database. Compared to available literature models and results, 13 %-26 % improvement in diagnostic accuracy is observed. Additionally, the proposed methodology also supports individualized ADHA severity assessment by regression analysis in the latent space and provides a potential tool for personalized treatment. Finally, an ADHD sensitivity map is developed, highlighting brain regions associated with ADHD scores and providing interpretable insights into ADHD's neural underpinnings.

Indexed as

ADHDCAMELDiagnosisDimension reductionrs-fMRI

Identifiers

PMID40917870
PMCPMC12409445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.